General Information of the Compound
| Compound ID |
CP0866986
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-5-[3-(2-{[4-(4-hydroxy-1-piperidinyl)-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C37H33F2N7O4
|
||||||||||||||||||
| Molecular Weight |
677.712
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(N2CCC(O)CC2)ccc1Nc1nccc(-c2c(-c3ccc(OC)c(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C37H33F2N7O4/c1-49-30-12-9-22(20-25(30)36(48)44-34-26(38)6-5-7-27(34)39)33-35(46-17-4-3-8-32(46)43-33)29-13-16-40-37(42-29)41-28-11-10-23(21-31(28)50-2)45-18-14-24(47)15-19-45/h3-13,16-17,20-21,24,47H,14-15,18-19H2,1-2H3,(H,44,48)(H,40,41,42)
Show/Hide
|
||||||||||||||||||
| InChIKey |
IZWMXHKTMDDTDD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor